• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向骨肉瘤的机械转导:比较肿瘤学视角。

Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective.

机构信息

Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

出版信息

Int J Mol Sci. 2020 Oct 14;21(20):7595. doi: 10.3390/ijms21207595.

DOI:10.3390/ijms21207595
PMID:33066583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7589883/
Abstract

Mechanotransduction is the process in which cells can convert extracellular mechanical stimuli into biochemical changes within a cell. While this a normal process for physiological development and function in many organ systems, tumour cells can exploit this process to promote tumour progression. Here we summarise the current state of knowledge of mechanotransduction in osteosarcoma (OSA), the most common primary bone tumour, referencing both human and canine models and other similar mesenchymal malignancies (e.g., Ewing sarcoma). Specifically, we discuss the mechanical properties of OSA cells, the pathways that these cells utilise to respond to external mechanical cues, and mechanotransduction-targeting strategies tested in OSA so far. We point out gaps in the literature and propose avenues to address them. Understanding how the physical microenvironment influences cell signalling and behaviour will lead to the improved design of strategies to target the mechanical vulnerabilities of OSA cells.

摘要

机械转导是细胞将细胞外机械刺激转化为细胞内生化变化的过程。虽然这是许多器官系统中生理发育和功能的正常过程,但肿瘤细胞可以利用这个过程来促进肿瘤的进展。在这里,我们总结了骨肉瘤(OSA)中机械转导的最新知识状态,OSA 是最常见的原发性骨肿瘤,参考了人类和犬类模型以及其他类似的间充质恶性肿瘤(例如尤文肉瘤)。具体来说,我们讨论了 OSA 细胞的机械特性、这些细胞用于响应外部机械线索的途径,以及迄今为止在 OSA 中测试的机械转导靶向策略。我们指出了文献中的差距,并提出了解决这些差距的途径。了解物理微环境如何影响细胞信号转导和行为将导致改进设计靶向 OSA 细胞机械脆弱性的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e65/7589883/5ad00111d542/ijms-21-07595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e65/7589883/025fb03f76b3/ijms-21-07595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e65/7589883/5ad00111d542/ijms-21-07595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e65/7589883/025fb03f76b3/ijms-21-07595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e65/7589883/5ad00111d542/ijms-21-07595-g002.jpg

相似文献

1
Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective.靶向骨肉瘤的机械转导:比较肿瘤学视角。
Int J Mol Sci. 2020 Oct 14;21(20):7595. doi: 10.3390/ijms21207595.
2
An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.一项关于犬骨肉瘤中TAZ和YAP与TGFβ信号通路相互作用的评估表明,河马信号通路参与了疾病进展。
BMC Vet Res. 2018 Nov 26;14(1):365. doi: 10.1186/s12917-018-1651-5.
3
Developmental pathways hijacked by osteosarcoma.成骨肉瘤中被劫持的发育途径。
Adv Exp Med Biol. 2014;804:93-118. doi: 10.1007/978-3-319-04843-7_5.
4
Role of ezrin in osteosarcoma metastasis.埃兹蛋白在骨肉瘤转移中的作用。
Adv Exp Med Biol. 2014;804:181-201. doi: 10.1007/978-3-319-04843-7_10.
5
New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?原发性骨肿瘤及其微环境中 Wnt/β-连环蛋白信号通路的新见解:开发治疗策略的有前途靶点?
Int J Mol Sci. 2019 Jul 31;20(15):3751. doi: 10.3390/ijms20153751.
6
Recent Advances in Mechanobiology of Osteosarcoma.骨肉瘤力学生物学的最新进展
J Cell Biochem. 2017 Feb;118(2):232-236. doi: 10.1002/jcb.25660. Epub 2016 Aug 16.
7
Cancer stem cells in osteosarcoma.骨肉瘤中的癌症干细胞。
Cancer Lett. 2017 Feb 1;386:189-195. doi: 10.1016/j.canlet.2016.11.019. Epub 2016 Nov 25.
8
BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.BMI1在犬骨肉瘤中表达,并促进细胞生长和化疗耐药性。
PLoS One. 2015 Jun 25;10(6):e0131006. doi: 10.1371/journal.pone.0131006. eCollection 2015.
9
Osteosarcoma mechanobiology and therapeutic targets.骨肉瘤的力学生物学和治疗靶点。
Br J Pharmacol. 2022 Jan;179(2):201-217. doi: 10.1111/bph.15713. Epub 2021 Dec 21.
10
Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.核因子κB受体激活剂配体表达作为原发性骨肿瘤的新治疗靶点
PLoS One. 2016 May 10;11(5):e0154680. doi: 10.1371/journal.pone.0154680. eCollection 2016.

引用本文的文献

1
3D-printed β-TCP scaffold as a bone-mimicking environment for an engineered model of osteosarcoma: properties and transcriptomic insights.3D打印β-磷酸三钙支架作为骨肉瘤工程模型的骨模拟环境:特性与转录组学见解
Mater Today Bio. 2025 Apr 12;32:101766. doi: 10.1016/j.mtbio.2025.101766. eCollection 2025 Jun.
2
Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders.Hippo-YAP/TAZ 信号通路在肌肉骨骼疾病中的新兴作用和功能。
Stem Cell Res Ther. 2024 Oct 29;15(1):386. doi: 10.1186/s13287-024-04011-9.
3
Extracellular matrix production and oxygen diffusion regulate chemotherapeutic response in osteosarcoma spheroids.

本文引用的文献

1
Phosphorylated Ezrin (Thr567) Regulates Hippo Pathway and Yes-Associated Protein (Yap) in Liver.磷酸化 Ezrin(Thr567)调节肝脏中的 Hippo 通路和 Yes 相关蛋白(Yap)。
Am J Pathol. 2020 Jul;190(7):1427-1437. doi: 10.1016/j.ajpath.2020.03.014. Epub 2020 Apr 11.
2
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma.色瑞替尼与达沙替尼联合用于骨肉瘤的安全性及活性
Cancers (Basel). 2020 Mar 26;12(4):793. doi: 10.3390/cancers12040793.
3
Cisplatin Resistance in Osteosarcoma: Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments.
细胞外基质的产生和氧气扩散调节骨肉瘤球体中的化疗反应。
Cancer Med. 2024 Sep;13(18):e70239. doi: 10.1002/cam4.70239.
4
Biomechanical Aspects in Bone Tumor Engineering.骨肿瘤工程中的生物力学方面。
Tissue Eng Part B Rev. 2024 Apr;30(2):217-229. doi: 10.1089/ten.TEB.2023.0106. Epub 2023 Nov 16.
5
Cyclic Stretch-Induced Mechanical Stress Applied at 1 Hz Frequency Can Alter the Metastatic Potential Properties of SAOS-2 Osteosarcoma Cells.周期性拉伸诱导的 1 Hz 频率机械应力可改变 SAOS-2 骨肉瘤细胞的转移潜能特性。
Int J Mol Sci. 2023 Apr 22;24(9):7686. doi: 10.3390/ijms24097686.
6
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer.针对原发性骨癌中的IGF/PI3K/mTOR通路和AXL/YAP1/TAZ通路。
J Bone Oncol. 2022 Feb 24;33:100419. doi: 10.1016/j.jbo.2022.100419. eCollection 2022 Apr.
7
mTOR Signaling Components in Tumor Mechanobiology.肿瘤机械生物学中的 mTOR 信号成分。
Int J Mol Sci. 2022 Feb 5;23(3):1825. doi: 10.3390/ijms23031825.
8
Osteosarcoma mechanobiology and therapeutic targets.骨肉瘤的力学生物学和治疗靶点。
Br J Pharmacol. 2022 Jan;179(2):201-217. doi: 10.1111/bph.15713. Epub 2021 Dec 21.
9
Investigation of inhibition effect of daidzein on osteosarcoma cells based on experimental validation and systematic pharmacology analysis.基于实验验证和系统药理学分析的大豆苷元对骨肉瘤细胞抑制作用的研究
PeerJ. 2021 Aug 31;9:e12072. doi: 10.7717/peerj.12072. eCollection 2021.
骨肉瘤中的顺铂耐药性:用于个体化治疗的候选DNA修复相关治疗靶点和药物的验证
Front Oncol. 2020 Mar 10;10:331. doi: 10.3389/fonc.2020.00331. eCollection 2020.
4
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.针对癌症治疗的 YAP/TAZ-TEAD 癌蛋白的斗争。
Theranostics. 2020 Feb 18;10(8):3622-3635. doi: 10.7150/thno.40889. eCollection 2020.
5
Recent and current clinical trials in canine appendicular osteosarcoma.犬附肢骨肉瘤的近期及当前临床试验。
Can Vet J. 2020 Mar;61(3):301-308.
6
Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.理解和模拟转移生物学以改进对抗骨肉瘤进展的治疗策略。
Front Oncol. 2020 Jan 31;10:13. doi: 10.3389/fonc.2020.00013. eCollection 2020.
7
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties.将正常细胞重编程为肿瘤前体细胞需要细胞外基质的硬度和癌基因介导的细胞力学性质的改变。
Nat Mater. 2020 Jul;19(7):797-806. doi: 10.1038/s41563-020-0615-x. Epub 2020 Feb 17.
8
YAP/TAZ functions and their regulation at a glance.YAP/TAZ 的功能及其调控一览
J Cell Sci. 2020 Jan 29;133(2):jcs230425. doi: 10.1242/jcs.230425.
9
Direct evidence that tumor cells soften when navigating confined spaces.肿瘤细胞在受限空间中迁移时会变软的直接证据。
Mol Biol Cell. 2020 Jul 21;31(16):1726-1734. doi: 10.1091/mbc.E19-10-0588. Epub 2020 Jan 29.
10
Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.不同转移倾向的骨肉瘤细胞缺氧诱导的蛋白质组变化的描绘。
Sci Rep. 2020 Jan 20;10(1):727. doi: 10.1038/s41598-019-56878-x.